[Symptomatic treatment of painful diabetic neuropathy].
Maeda
Kengo
K
Department of Medicine, Shiga University of Medical Science.
Yasuda
Hitoshi
H
D000588:Amines / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D003915:Dextromethorphan / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000209:etiology / Q000628:therapy*; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077206:Gabapentin; D005727:Ganglia, Spinal / Q000502:physiology; D006801:Humans; D000077213:Lamotrigine; D008801:Mexiletine / Q000627:therapeutic use*; D009412:Nerve Fibers / Q000502:physiology; D020671:Posterior Horn Cells / Q000502:physiology; D000069583:Pregabalin; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D015222:Sodium Channels / Q000502:physiology; D000077236:Topiramate; D014227:Triazines / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*
D000588:Amines; D018927:Anti-Asthmatic Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000996:Antitussive Agents; D003509:Cyclohexanecarboxylic Acids; D003915:Dextromethorphan; D005632:Fructose; D000077206:Gabapentin; D000077213:Lamotrigine; D008801:Mexiletine; D000069583:Pregabalin; D017367:Selective Serotonin Reuptake Inhibitors; D015222:Sodium Channels; D000077236:Topiramate; D014227:Triazines; D005680:gamma-Aminobutyric Acid